Mar 16 2012

AudioCure completes successful the initial financing round with High-Tech-Gründerfonds

Bonn / Berlin – 29.05.2012 High-Tech Gründerfonds and Business Angel Invest in AudioCure Pharma GmbH Drug Development AudioCure Pharma concentrates on the clinical development of drug candidates in neurological disease indications with a high unmet medical need. The lead candidate is a small molecule compound for the treatment of acute and chronic hearing impairments via(…)

Mar 1 2012

Coordinator in the KMUi project NeuroPro

As a result of increasing life expectancy, the prevalence of neurological disorders has also significantly increased worldwide. Three of the most severely affected disorders are Alzheimer’s Disease, Parkinson’s Disease and hearing loss.  The latter can be a consequence of age, tinnitus and noise-damage. Therefore, the primary subject of the joint venture project NeuroPro is the(…)